Surgical Treatment of Chronic Neuropathic Pain (Rethink Pain)
An Ambispective, Multicenter, Observational Registry Study of Patients Considering Surgical Treatment for Chronic Neuropathic Pain
Sponsor: Axogen Corporation
Terminated
The study was terminated due to lower than expected enrollment. The decision to terminate the study was not based on any safety or efficacy concerns.
Other terminated trials from Axogen Corporation
- Breast Cancer · Phase NA · Sep 2024
- Acute Upper Extremity Trauma · Dec 2020
- Traumatic Nerve Injury · Phase NA · Dec 2014
More terminations from Axogen Corporation
This observational or N/A phase trial investigates Chronic Neuropathic Pain and is currently terminated or withdrawn. Axogen Corporation leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2024 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Apr 2023 — Apr 2024 [monthly]
Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
-
Jun 2021 — Jun 2022 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Mar 2020 — May 2020 [monthly]
Recruiting
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Axogen Corporation
For direct contact, visit the study record on ClinicalTrials.gov .